IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 19 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,468,000 | +0.1% | 250,000 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $2,466,000 | -1.6% | 250,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,505,000 | +0.2% | 250,000 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $2,499,000 | -0.6% | 250,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $2,513,000 | +1.9% | 250,000 | 0.0% | 0.01% | -15.4% |
| Q1 2021 | $2,465,000 | – | 250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |